Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-3-16
pubmed:abstractText
Optineurin (OPTN) is a multifunctional protein involved in vesicular trafficking, signal transduction and gene expression. OPTN mutations were described in eight Japanese patients with familial and sporadic amyotrophic lateral sclerosis (FALS, SALS). OPTN-positive inclusions co-localising with TDP-43 were described in SALS and in FALS with SOD-1 mutations, potentially linking two pathologically distinct pathways of motor neuron degeneration. We have explored the abundance of OPTN inclusions using a range of antibodies in postmortem tissues from 138 cases and controls including sporadic and familial ALS, frontotemporal lobar degeneration (FTLD) and a wide range of neurodegenerative proteinopathies. OPTN-positive inclusions were uncommon and detected in only 11/32 (34%) of TDP-43-positive SALS spinal cord and 5/15 (33%) of FTLD-TDP. Western blot of lysates from FTLD-TDP frontal cortex and TDP-43-positive SALS spinal cord revealed decreased levels of OPTN protein compared to controls (p < 0.05), however, this correlated with decreased neuronal numbers in the brain. Large OPTN inclusions were not detected in FALS with SOD-1 and FUS mutation, respectively, or in FTLD-FUS cases. OPTN-positive inclusions were identified in a few Alzheimer's disease (AD) cases but did not co-localise with tau and TDP-43. Occasional striatal neurons contained granular cytoplasmic OPTN immunopositivity in Huntington's disease (HD) but were absent in spinocerebellar ataxia type 3. No OPTN inclusions were detected in FTLD-tau and ?-synucleinopathy. We conclude that OPTN inclusions are relatively rare and largely restricted to a minority of TDP-43 positive ALS and FTLD-TDP cases. Our results do not support the proposition that OPTN inclusions play a central role in the pathogenesis of ALS, FTLD or any other neurodegenerative disorder.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/DAPI, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Histamine Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/OPTN protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Superoxide Dismutase, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor TFIIIA, http://linkedlifedata.com/resource/pubmed/chemical/Tubulin, http://linkedlifedata.com/resource/pubmed/chemical/beta III-tubulin protein, human, http://linkedlifedata.com/resource/pubmed/chemical/protein TDP-43, http://linkedlifedata.com/resource/pubmed/chemical/superoxide dismutase 1
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1432-0533
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
519-27
pubmed:meshHeading
pubmed-meshheading:21360076-Aged, pubmed-meshheading:21360076-Aged, 80 and over, pubmed-meshheading:21360076-Amyotrophic Lateral Sclerosis, pubmed-meshheading:21360076-Brain, pubmed-meshheading:21360076-DNA-Binding Proteins, pubmed-meshheading:21360076-Female, pubmed-meshheading:21360076-Frontotemporal Lobar Degeneration, pubmed-meshheading:21360076-Histamine Agonists, pubmed-meshheading:21360076-Humans, pubmed-meshheading:21360076-Indoles, pubmed-meshheading:21360076-Male, pubmed-meshheading:21360076-Middle Aged, pubmed-meshheading:21360076-Mutation, pubmed-meshheading:21360076-Nerve Tissue Proteins, pubmed-meshheading:21360076-Neurons, pubmed-meshheading:21360076-Spinal Cord, pubmed-meshheading:21360076-Superoxide Dismutase, pubmed-meshheading:21360076-Transcription Factor TFIIIA, pubmed-meshheading:21360076-Tubulin
pubmed:year
2011
pubmed:articleTitle
Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
pubmed:affiliation
Department of Clinical Neuroscience, King's College London, MRC Centre for Neurodegeneration Research, Institute of Psychiatry, De Crespigny Park, London SE58AF, UK. tibor.hortobagyi@kcl.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't